Skip to main content

Table 5 Comorbidities associated to geriatric outcome scores in ACRO by multivariate analysis

From: Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study

 

IADL

BADL

TUG

SPPB

Cardio and cerebrovascular disease OR (IC 95%)

1.89* (1.17 - 3.03)

1.23 (0.77 - 1.98)

0.83 (0.51 - 1.33)

0.99 (0.62 - 1.59)

Respiratory disease OR (IC 95%)

0.39* (0.24 - 0.62)

0.60* (0.37 - 0.96)

1.91* (1.19 - 3.06)

0.54* (0.34 - 0.88)

Metabolic impairment OR (IC 95%)

0.95 (0.59 -1.53)

1.08 (0.67 - 1.74)

0.60 (0.38 – 0.97)

1.40 (0.87 - 2.25)

Goitre OR (IC 95%)

0.87 (0.54 - 1.40)

0.78 (0.49 - 1.26)

0.90 (0.56 - 1.44)

0.74 (0.46 - 1.19)

Endocrine dysfunctions OR (IC 95%)

1.19 (0.74 - 1.91)

0.34* (0.21 - 0.54)

0.63* (0.39 - 1.01)

1.05 (0.65 - 1.69)

Oncological disease OR (IC 95%)

1.43 (0.89 - 2.30)

1.23 (0.77 - 1.98)

0.85 (0.53 - 1.36)

1.43 (0.89 - 2.30)

Digestive diseases OR (IC 95%)

0.86* (0.54 - 1.39)

0.85* (0.53 - 1.37)

1.52* (0.95 - 2.45)

0.69* (0.43 - 1.10)

Psychiatric OR (IC 95%)

0.49 (0.31 - 0.79)

0.48 (0.30 – 0.77)

1.08 (0.67 - 1.74)

0.84 (0.52 - 1.34)

Musculoskeletal diseases OR (IC 95%)

0.89 (0.55 - 1.42)

0.89 (0.56 - 1.44)

1.73* (1.08 - 2.78)

0.89 (0.55 - 1.42)

Bone diseases OR (IC 95%)

1.03* (0.64 - 1.65)

1.36* (0.85 - 2.19)

1.11* (0.69 - 1.79)

0.67* (0.42 – 1.08)

  1. *P < 0.05